In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Artes Biotechnology GmbH

www.artes-biotechnology.com

Latest From Artes Biotechnology GmbH

Sun Dips Toe Into Vaccines With Dengvaxia Challenge

India's top-ranked drug firm Sun Pharma is vying for a play in the dengue vaccines space via a collaboration with the non-profit research organization, International Centre for Genetic Engineering and Biotechnology. The partners expect their vaccine candidate to potentially best live-attenuated dengue vaccine candidates, including Sanofi's Dengvaxia.

Research & Development Strategy

Indonesia’s Bio Farma Gains Boost From Germany’s Artes Biotechnology To Expand Vaccines Output

Bio Farma says new technology will help expand vaccines production and work on a hepatitis B vaccine as the country moves to launch a phased universal health care insurance program next year.

BioPharmaceutical Indonesia

Deals Shaping the Medical Industry (11/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions

Deals Shaping the Medical Industry (06/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Artes Biotechnology GmbH
  • Senior Management
  • Michael Piontek, PhD, Managing Dir.
    Melanie Dröttboom, PhD, Dir., Bus. Dev.
    Adelheid Degelmann, PhD, Sr. Scientist
  • Contact Info
  • Artes Biotechnology GmbH
    Phone: (49) 2173 275870
    Elisabeth-Selbert-Str. 9
    Langenfeld, 40764
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register